Overall, insoluble fractions from AD cases contained greater amounts of phosphorylated tau compared with insoluble fractions from controls, indicating that our biochemical approaches yielded results comparable to past findings (Hanger et al., 1991; Koss et al., 2018). Here, MAPT is linked to Alzheimer disease.